Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.410
+0.040 (2.92%)
At close: Oct 15, 2026, 4:00 PM EDT
1.420
+0.010 (0.71%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Pulmatrix Earnings Call Transcripts
Fiscal Year 2024
-
Pulmatrix and Cullgen will merge, with Cullgen stockholders owning 96.4% of the combined entity, which will operate under the Cullgen name and focus on targeted protein degraders and DACs. The merger, expected to close by March 2025, brings $65M in cash and a robust clinical pipeline.